FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma

Author： Megison Michael  

Publisher： Springer Publishing Company

ISSN： 0262-0898

Source： Clinical and Experimental Metastasis, Vol.30, Iss.5, 2013-06, pp. : 555-568

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27Kip1 activity in neuroblastoma

By              

International Journal of Oncology, Vol. 42, Iss. 4, 2013-01 ,pp. : 1219-1228

Spandidos Publications

Access to resources Recommend Favorite

The Interaction Between FAK, MYCN, p53 and Mdm2 in Neuroblastoma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 1, 2014-01 ,pp. : 46-51

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of cancer cell invasion and metastasis by genistein

By Pavese Janet  

Cancer and Metastasis Reviews, Vol. 29, Iss. 3, 2010-09 ,pp. : 465-482

Springer Publishing Company

Access to resources Recommend Favorite

Vandetanib-induced inhibition of neuroblastoma cell migration and invasion is associated with downregulation of the SDF-1/CXCR4 axis and matrix metalloproteinase 14

By                  

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1165-1174

Spandidos Publications

Access to resources Recommend Favorite

Silencing of galectin-3 represses osteosarcoma cell migration and invasion through inhibition of FAK/Src/Lyn activation and β-catenin expression and increases susceptibility to chemotherapeutic agents

By  

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 185-194

Spandidos Publications

Access to resources Recommend Favorite